CJ Bioscience, Inc. (KOSDAQ:A311690) agreed to acquire Red BIO business of CJ Cheiljedang Corporation (KOSE:A097950) for KRW 6.1 billion on November 8, 2021. The transaction is expected to close on January 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,790 KRW | +3.14% | +7.10% | -8.36% |
1st Jan change | Capi. | |
---|---|---|
-8.36% | 97.38M | |
+0.36% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.77% | 24.63B | |
-23.26% | 18.2B | |
+27.79% | 12.01B | |
-2.48% | 11.76B | |
+14.10% | 10.4B | |
-4.85% | 9.94B |
- Stock Market
- Equities
- A311690 Stock
- News CJ Bioscience, Inc.
- CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.